Poly-lysine peptidomimetics having potent antimicrobial activity without hemolytic activity
Mija Ahn1, Binu Jacob, Pethaiah Gunasekaran
1Division of Magnetic Resonance, Korea Basic Science Institute, 804-1 Yangchung-ri, Ochang, Chungbuk, 363-883, Republic of Korea.
Amino Acids
|June 26, 2014
Summary
Researchers developed short peptidomimetics that effectively kill bacteria, including MRSA, without causing red blood cell damage. Structure-activity relationship studies identified key factors like hydrophobicity and charge for potent antimicrobial activity.
Area of Science:
- Medicinal Chemistry
- Biochemistry
- Microbiology
Background:
- Naturally occurring antimicrobial peptides (AMPs) exhibit sequence and structural diversity, hindering detailed structure-activity relationship (SAR) studies.
- Peptidomimetics offer advantages over natural AMPs, including simpler structures, ease of synthesis, and rapid property elucidation for drug development.
Purpose of the Study:
- To design and synthesize short peptidomimetics for antimicrobial applications.
- To investigate the SAR of these peptidomimetics against various bacterial strains.
- To elucidate the bacterial-killing mechanism of the developed peptidomimetics.
Main Methods:
- Synthesis of peptidomimetics comprising multiple lysine residues and lipophilic moieties.
- Antimicrobial activity assays against Gram-negative and Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA).
- Hemolytic activity assays, membrane depolarization studies, dye leakage assays, inner membrane permeability tests, and time-killing kinetics.
Main Results:
- Synthesized peptidomimetics demonstrated potent activity against a range of bacteria, including MRSA, with no observed hemolytic activity.
- SAR studies revealed that hydrophobicity, positive charge from lysine residues, hydrocarbon tail length, and the presence of a cyclohexyl group are critical for antimicrobial efficacy.
- Mechanism of action studies indicated that these peptidomimetics likely target intracellular components rather than bacterial membranes, distinguishing them from conventional membrane-targeting AMPs.
Conclusions:
- Short peptidomimetics can be effectively designed to target bacterial pathogens, offering a promising alternative to natural AMPs.
- Key structural features, including hydrophobicity and charge, are crucial for optimizing antimicrobial activity.
- The distinct intracellular-targeting mechanism suggests a novel approach for combating bacterial infections, potentially overcoming resistance mechanisms associated with membrane-targeting agents.
Related Concept Videos
01:23Inhibitors of Gram-positive Cell Wall Synthesis
179
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
179
01:25Inhibitors of Bacterial Protein Synthesis
102
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
102
01:23Antimicrobial Proteins
10.6K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
10.6K